Related Experiment Videos
Gender difference in ifosfamide metabolism by human liver microsomes
R Schmidt1, F Baumann, H Hanschmann
1Institute of Clinical Pharmacology, University of Leipzig, Germany.
European Journal of Drug Metabolism and Pharmacokinetics
|November 7, 2001
Summary
Gender differences in drug metabolism are significant. Female liver microsomes show higher ifosfamide N-dechloroethylation activity, potentially increasing neurotoxicity risk in women.
Area of Science:
- Pharmacology
- Drug Metabolism
- Biochemistry
Background:
- Gender-specific pharmacokinetic differences in cytochrome P450 (CYP) enzyme activity are increasingly recognized.
- CYP3A4 is crucial for ifosfamide metabolism, yet gender-related variations in its activity are not well-documented.
Purpose of the Study:
- To investigate gender-related differences in the content and activity of CYP enzymes involved in ifosfamide metabolism.
- To compare ifosfamide 4-hydroxylation and N-dechloroethylation in male and female liver microsomes.
Main Methods:
- Analysis of CYP3A4, CYP2A6, CYP2C9, and CYP2B6 content and activity in 10 male and 10 female liver microsomal preparations.
- In vitro assessment of ifosfamide 4-hydroxylation and N-dechloroethylation using HPLC/MS and HPLC/UV detection.
Main Results:
- Significant gender differences observed in mean CYP3A4 content and activity, but not impacting ifosfamide 4-hydroxylation.
- A statistically significant difference in ifosfamide N-dechloroethylation activity was found between male (0.13 +/- 0.05 nmol/min nmol P450) and female (0.28 +/- 0.13 nmol/min x nmolP450) liver microsomes.
Conclusions:
- This study provides the first evidence of gender-related differences in ifosfamide N-dechloroethylation.
- Higher N-dechloroethylation activity in females may elevate the risk of severe neurotoxic side effects from ifosfamide treatment.